Advertisement

Picture Berlin Partner Bionnale 2021 Digital Event 650x80px
Financing › Details

Transgene–SEVERAL: investment, 201906–201907 capital increase €48.7m w preferential subscription rights 20.8m shares at €2.34/share

 

Period Period 2019-06-14 ï¿½ 2019-07-02
Organisations Money taker Transgene S.A. (Euronext: TNG)
  Group Mérieux (Group)
  Money source SEVERAL
Products Product Invir.IO™ oncolytic virus technology platform
  Product 2 investment banking
Document Source Transgene S.A.. (7/2/19). "Press Release: Success of Transgene’s €48.7 Million Rights Issue [This document must not be distributed, directly or indirectly, in the United States of America, Australia, Canada or Japan]". Strasbourg.
     

   
Record changed: 2020-01-06

Advertisement

Picture EBD Group Global Partnering Four Events One Price 650x80

More documents for Mérieux (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Advertisement

Picture Berlin Partner Network in German Capital Region 650x80px




» top